000 01388nam  2200337zi 4500
0019.901201
003CaOODSP
00520221107175618
006m     o  d f      
007cr cn|||||||||
008210628t20212020onca    o    f000 0 eng d
020 |a9780660393919
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn-qu
0861 |aNR16-361/2021E-PDF
24500|aBiologics Manufacturing Centre and Novavax.
264 1|a[Ottawa] : |bNational Research Council Canada = Conseil national de recherches Canada, |c[2021]
264 4|c©2020
300 |a1 online resource (1 page) : |bcolour illustration
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Centre de production de produits biologiques et Novavax.
530 |aIssued also in printed form.
650 0|aDrug factories|zQuébec (Province)|zMontréal.
650 0|aVaccines|xBiotechnology|zQuébec (Province)|zMontréal.
7102 |aNational Research Council Canada, |eissuing body.
77508|tCentre de production de produits biologiques et Novavax.|w(CaOODSP)9.901200
7760#|tBiologics Manufacturing Centre and Novavax|w(CaOODSP)9.901199
85640|qPDF|s160 KB|uhttps://publications.gc.ca/collections/collection_2021/cnrc-nrc/NR16-361-2021-eng.pdf